KR890002141A - 무정형 아즈트레오남 - Google Patents
무정형 아즈트레오남 Download PDFInfo
- Publication number
- KR890002141A KR890002141A KR1019880007972A KR880007972A KR890002141A KR 890002141 A KR890002141 A KR 890002141A KR 1019880007972 A KR1019880007972 A KR 1019880007972A KR 880007972 A KR880007972 A KR 880007972A KR 890002141 A KR890002141 A KR 890002141A
- Authority
- KR
- South Korea
- Prior art keywords
- amorphous
- amino
- aztreonam
- arginine
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (3)
- 비결정, 무정형 [3S-[3(Z), 4]]-3-[[2-아미노-4-티나졸릴[1-카르복시-1-메킬에톡시)이미노]아세틸]아미노]-4-메틸-2-옥소-1-아제티딘술폰산 및 그의 제약상 허용되는 염.
- 결정성 아즈트레오남을 L-아르기닌과 혼합시키고, 이 혼합물을 물 중에 용해시키고, 용해된 혼합물을 동결-건조시키는 것으로 되는 제1항의 화합물의 제조방법.
- 제1항에 있어서, 제약상 허용되는 염이 L-아르기닌인 화합물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6839287A | 1987-07-01 | 1987-07-01 | |
US068,392 | 1987-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890002141A true KR890002141A (ko) | 1989-04-08 |
Family
ID=22082279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880007972A KR890002141A (ko) | 1987-07-01 | 1988-06-30 | 무정형 아즈트레오남 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0297580B1 (ko) |
JP (1) | JP2701869B2 (ko) |
KR (1) | KR890002141A (ko) |
CN (1) | CN1028234C (ko) |
AT (1) | ATE175965T1 (ko) |
CA (1) | CA1339136C (ko) |
DE (1) | DE3856297T2 (ko) |
ES (1) | ES2127178T3 (ko) |
GR (1) | GR3029873T3 (ko) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN191492B (ko) * | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
DE60134679D1 (de) | 2000-10-20 | 2008-08-14 | Eisai R&D Man Co Ltd | Stickstoff enthaltende aromatische Heterozyklen |
US7214364B2 (en) | 2000-12-27 | 2007-05-08 | Corus Pharma, Inc. | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
US7138419B2 (en) | 2000-12-27 | 2006-11-21 | Corus Pharma, Inc. | Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate |
ES2406405T3 (es) | 2000-12-27 | 2013-06-06 | Gilead Sciences, Inc. | Aztreonam inhalable sin arginina para tratamiento y prevención de infecciones bacterianas pulmonares |
US7145017B2 (en) | 2002-08-05 | 2006-12-05 | TEVA Gyógyszergyár Zártkörűen Működő Részvénytársaság | Preparation of Aztreonam |
WO2004052333A1 (en) * | 2002-12-11 | 2004-06-24 | Pari Gmbh | Pharmaceutical compositions for the pulmonary delivery of aztreonam |
US7994159B2 (en) | 2003-03-10 | 2011-08-09 | Eisai R&D Management Co., Ltd. | c-Kit kinase inhibitor |
WO2004103999A1 (en) | 2003-05-15 | 2004-12-02 | TEVA Gyógyszergyár Részvénytársaság | AZTREONAM β POLYMORPH WITH VERY LOW RESIDUAL SOLVENT CONTENT |
US7262293B2 (en) | 2003-07-02 | 2007-08-28 | Corus Pharma | Aztreonam L-lysine and methods for the preparation thereof |
CA2543650C (en) | 2003-12-25 | 2010-10-26 | Eisai Co., Ltd. | A crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same |
US8969379B2 (en) | 2004-09-17 | 2015-03-03 | Eisai R&D Management Co., Ltd. | Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide |
JP2008505189A (ja) | 2005-05-09 | 2008-02-21 | シコール インコーポレイティド | アズトレオナムの製造方法 |
CN101233111A (zh) * | 2005-06-23 | 2008-07-30 | 卫材R&D管理有限公司 | 4-(3-氯-4-(环丙基氨基羰基)氨基苯氧基)-7-甲氧基-6-喹啉羧酸酰胺的无定形盐及其制备方法 |
US7550483B2 (en) | 2005-06-23 | 2009-06-23 | Eisai R&D Management Co., Ltd. | Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for preparing the same |
EP1925676A4 (en) | 2005-08-02 | 2010-11-10 | Eisai R&D Man Co Ltd | TEST METHOD FOR THE EFFECT OF A VASCULARIZATION INHIBITOR |
ES2556173T3 (es) | 2006-05-18 | 2016-01-13 | Eisai R&D Management Co., Ltd. | Agente antitumoral para un cáncer de tiroides |
US8865737B2 (en) | 2006-08-28 | 2014-10-21 | Eisai R&D Management Co., Ltd. | Antitumor agent for undifferentiated gastric cancer |
EP2119707B1 (en) | 2007-01-29 | 2015-01-14 | Eisai R&D Management Co., Ltd. | Composition for treatment of undifferentiated-type of gastric cancer |
CN101848895B (zh) | 2007-11-09 | 2013-10-23 | 卫材R&D管理有限公司 | 血管新生抑制物质和抗肿瘤性铂络合物的组合使用 |
CN101579336B (zh) * | 2009-07-07 | 2010-06-23 | 重庆市庆余堂制药有限公司 | 一种注射用氨曲南及其生产方法 |
US9012458B2 (en) | 2010-06-25 | 2015-04-21 | Eisai R&D Management Co., Ltd. | Antitumor agent using compounds having kinase inhibitory effect in combination |
CN101912356B (zh) * | 2010-08-02 | 2012-01-11 | 王明 | 一种氨曲南/精氨酸药物组合物脂微球注射剂 |
WO2012144463A1 (ja) | 2011-04-18 | 2012-10-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 腫瘍治療剤 |
WO2012166899A2 (en) | 2011-06-03 | 2012-12-06 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
KR20150098605A (ko) | 2012-12-21 | 2015-08-28 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 퀴놀린 유도체의 비정질 형태 및 그의 제조방법 |
KR102204279B1 (ko) | 2013-05-14 | 2021-01-15 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 자궁내막암 대상의 렌바티닙 화합물에 대한 반응성을 예측 및 평가하기 위한 생체표지 |
RS63559B1 (sr) | 2014-08-28 | 2022-10-31 | Eisai R&D Man Co Ltd | Derivat hinolina velike čistoće i postupak za njegovu proizvodnju |
PL3263106T3 (pl) | 2015-02-25 | 2024-04-02 | Eisai R&D Management Co., Ltd. | Sposób tłumienia goryczy pochodnej chinoliny |
AU2015384801B2 (en) | 2015-03-04 | 2022-01-06 | Eisai R&D Management Co., Ltd. | Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer |
BR112017027227B1 (pt) | 2015-06-16 | 2023-12-12 | Eisai R&D Management Co., Ltd | Agente anti-câncer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1181075A (en) * | 1981-07-13 | 1985-01-15 | David M. Floyd | CRYSTALLINE ANHYDROUS FORM OF [3-S-[3.alpha.(Z),4 .beta.]]-3-[[(2-AMINO-4-THIAZOLYL) [(1-CARBOXY-1-METHYLETHOXY)IMINO]ACETYL] AMINO]-4-METHYL-2-OXO-1-AZETIDINESULFONIC ACID |
YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
-
1988
- 1988-06-28 CA CA000570624A patent/CA1339136C/en not_active Expired - Fee Related
- 1988-06-29 JP JP63162369A patent/JP2701869B2/ja not_active Expired - Lifetime
- 1988-06-29 CN CN88104073A patent/CN1028234C/zh not_active Expired - Fee Related
- 1988-06-30 AT AT88110480T patent/ATE175965T1/de not_active IP Right Cessation
- 1988-06-30 ES ES88110480T patent/ES2127178T3/es not_active Expired - Lifetime
- 1988-06-30 KR KR1019880007972A patent/KR890002141A/ko not_active Application Discontinuation
- 1988-06-30 EP EP88110480A patent/EP0297580B1/en not_active Expired - Lifetime
- 1988-06-30 DE DE3856297T patent/DE3856297T2/de not_active Expired - Fee Related
-
1999
- 1999-04-05 GR GR990400962T patent/GR3029873T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA1339136C (en) | 1997-07-29 |
ES2127178T3 (es) | 1999-04-16 |
ATE175965T1 (de) | 1999-02-15 |
EP0297580B1 (en) | 1999-01-20 |
DE3856297T2 (de) | 1999-06-02 |
JPS6422874A (en) | 1989-01-25 |
GR3029873T3 (en) | 1999-07-30 |
CN1028234C (zh) | 1995-04-19 |
CN1030238A (zh) | 1989-01-11 |
EP0297580A1 (en) | 1989-01-04 |
JP2701869B2 (ja) | 1998-01-21 |
DE3856297D1 (de) | 1999-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890002141A (ko) | 무정형 아즈트레오남 | |
DE3769676D1 (de) | Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung. | |
BR9910928A (pt) | Composto, processo para a prepará-lo, uso do mesmo, formulação, e, processo para a profilaxia e/ou tratamento de condições clinicas associadas com resistência a insulina | |
SE8304045D0 (sv) | Derivat av morfolinyl-daunorubicin och morfolinyl-doxorubicin, och analoger derav samt forfarande for framstellning derav | |
ES514267A0 (es) | "un procedimiento para la preparacion de derivados de pirrolidina". | |
BR9503536A (pt) | Composto processo para sua preparação seu uso e composição farmacêutica | |
IL111184A (en) | Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin | |
DE3264415D1 (en) | The crystalline anhydrous form of (3s-(3 alpha(z),4 beta))-3-(((2-amino-4-thiazolyl)(1-carboxy-1-methylethoxy)-imino)-acetyl)-amino)-4-methyl-2-oxo-1-azetidinesulfonic acid, method for its preparation, mixture and pharmaceutical composition containing it | |
KR900700098A (ko) | 발기부전의 치료겸 진단용 플라복세이트 및 그 유도체 | |
KR900001715A (ko) | Bu-3608 유도체 | |
KR910005871A (ko) | 세팔로스포린계 주사용 제제 | |
ATE21509T1 (de) | Beta-lactam-essigsaeure-derivate, verfahren zu deren herstellung und deren verwendung als zwischenverbindungen fuer 1-azabicyclo(3.2.0)hept- 2-en-antibiotika. | |
KR870007164A (ko) | 모노술팍탐 | |
ES8506731A1 (es) | Un procedimiento para preparar derivados de cefalosporina | |
KR930006003A (ko) | 이미다졸릴메틸-피리딘류 화합물 | |
FI913713A0 (fi) | Nya bicykliska aminosubstituerade foereningar. | |
KR890002111A (ko) | 벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용 | |
KR880007528A (ko) | [3s(z)]-2[[[1-(2-아미노-4-티아졸릴)-2-[[2,2-디메틸-4-옥소-1-(술포옥시)-3-아제티디닐]아미노]-2-옥소에틸리덴]아미노]옥시]아세트산의 결정질 염류 | |
KR890003755A (ko) | 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물 | |
KR920014811A (ko) | 트리사이클릭 피리돈 유도체 | |
KR850000454A (ko) | 세팔로스포린 유도체의 제조방법 | |
KR880012518A (ko) | 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물 | |
SE8804696L (sv) | Dioxazocin- derivat, deras framstaellning och beredningar innehaallande desamma | |
HK1007428A1 (en) | (alfa-t-butyl aminomethyl-3,4-dichlorobenzyl) thioacetamide process for its preparation and its applications | |
DE3262231D1 (en) | A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
J2X2 | Appeal (before the supreme court) |
Free format text: APPEAL BEFORE THE SUPREME COURT FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL |